ReportsnReports - Drugs for treating congestive heart failure   global markets
Upcoming SlideShare
Loading in...5
×
 

ReportsnReports - Drugs for treating congestive heart failure global markets

on

  • 263 views

This report is a comprehensive business tool designed to provide an in-depth look at drugs for the congestive heart failure market. The geographic scope of the report is global with a special emphasis ...

This report is a comprehensive business tool designed to provide an in-depth look at drugs for the congestive heart failure market. The geographic scope of the report is global with a special emphasis on individual regions. The report describes the industry, its relationship to the healthcare industry and its participants, and trends for the future.

Statistics

Views

Total Views
263
Views on SlideShare
263
Embed Views
0

Actions

Likes
0
Downloads
1
Comments
0

0 Embeds 0

No embeds

Accessibility

Upload Details

Uploaded via as Adobe PDF

Usage Rights

© All Rights Reserved

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Processing…
Post Comment
Edit your comment

ReportsnReports - Drugs for treating congestive heart failure   global markets ReportsnReports - Drugs for treating congestive heart failure global markets Document Transcript

  • Drugs for Treating Congestive Heart Failure: Global MarketsPublished:October 2011No.Of Pages:184Price:US $ 4850INTRODUCTIONSTUDY GOALS AND OBJECTIVESThe objectives of the study are to present a comprehensive look at the drugs for treatingcongestive heart failure (CHF)—global market measurements of both the overall market andall possible market segments, and to forecast market and segment growth during the nextfive years.REASONS FOR STUDYThis BCC study will increase the awareness of drugs to treat congestive heart failure. Thestudy analyzes the global market for select drugs for treating the congestive heart failure. Itdoes so from different standpoints and addresses issues and trends affecting the market.Congestive heart failure drug manufacturers, driven by both research breakthroughs andincreased recognition of expanding market opportunities, have stepped up the pace ofdevelopment of innovative products. Because of the evolving nature of this important areaof study, executives of product development for congestive heart failure drugs must remainever vigilant of the changing environment and strive to keep abreast of new and currentlyused modalities in all facets of the market.SCOPE OF STUDYThis report is a comprehensive business tool designed to provide an in-depth look at drugsfor the congestive heart failure market. The geographic scope of the report is global with aspecial emphasis on individual regions. The report describes the industry, its relationship tothe healthcare industry and its participants, and trends for the future.Categories discussed in the report include:* Angiotensin converting enzyme (ACE) inhibitors/angiotensin II receptor blockerantagonists (ARBs)* Beta-adrenergic receptor blocking agents* Diuretics* Inotropic drugs/vasodilatorsAll categories are discussed in detail, describing each segment, identifying current productson the market, measuring market size, identifying market drivers, forecasting for 2010 to2016, and assessing the competitors and competitor market shares.
  • METHODOLOGY AND INFORMATION SOURCESBoth primary and secondary research methodologies were used in preparing this study. Theinformation and analysis presented in this BCC report are based on extensive first-handinterviews with primary research sources, including executives, product managers, andclinical specialists in the congestive heart failure drug development arena. Backgroundinformation was obtained from various government agencies, business and medicaljournals, trade magazines, and interviews with doctors and nurses involved in the treatmentof congestive heart failure.Key information from published literature was used to conduct interviews with more than 20industry participants to validate and obtain expert opinions on current and future trends inthe congestive heart failure drug market. Interviews were the primary basis fordevelopment of market size. Interviews were also used to confirm and/or adjust market sizeand market share estimates, as well as formulating market projections.All market data pertain to the global market at the manufacturer’s level. Data are expressedin current U.S. dollars. The base year was 2011. Historical data are provided for 2010 andforecast data are provided for 2016. Historical, base year, and forecast data are providedfor each market segment and subsegment. Market shares are provided for each marketsegment for the 2011 base year.ANALYST CREDENTIALSMary Anne Crandall is an expert industry analyst specializing in the pharmaceutical industryfor the last 20 years. She has completed several in-depth studies on various medical topicsrequiring both medical expertise and excellent knowledge of the pharmaceutical industry.Ms. Crandall has extensive knowledge in the medical field, has an M.S. in psychology, and iscurrently working on a PhD.Table Of ContentsChapter- 1: INTRODUCTION - ComplimentarySTUDY GOALS AND OBJECTIVESREASONS FOR STUDYSCOPE OF STUDYMETHODOLOGY AND INFORMATION SOURCESANALYST CREDENTIALSRELATED BCC REPORTSBCC ONLINE SERVICESDISCLAIMERChapter- 2: EXECUTIVE SUMMARYTable : TOTAL GLOBAL MARKET SIZE AND FORECAST FOR CHF PHARMACEUTICALS,THROUGH 2016Figure GLOBAL SUMMARY FIGURE : TOTAL GLOBAL MARKET SIZE AND FORECAST FOR CHFPHARMACEUTICALS, 2010–2016Chapter- 3: OVERVIEW
  • ETIOLOGYCOMPENSATIONCLINICAL PRESENTATION OF CHFDEMOGRAPHICSTREATMENTSPRODUCTSRESEARCH AND DEVELOPMENTChapter- 4: THE GLOBAL MARKETGROWTH BY GEOGRAPHIC REGIONGROWTH BY DRUG CLASSCOMPETITIVE ANALYSISTable 14 : GLOBAL CHF PHARMACEUTICAL MARKET BY COMPANY, 2011Figure 7 : GLOBAL CHF PHARMACEUTICAL MARKET SHARES BY COMPANY, 2011Table 15 : GLOBAL CHF MANUFACTURER PRODUCT PARTICIPATION BY DRUG TYPEChapter- 5: THE AMERICAS MARKETREGIONAL MARKETSCHF POPULATIONREGIONAL DEMOGRAPHICSAMERICAS CHF MARKET FORECASTTable 27 : AMERICAS CHF PHARMACEUTICAL MARKET BY GEOGRAPHIC REGION, THROUGH2016Figure 8 : AMERICAS CHF MARKET BY GEOGRAPHIC REGION, 2011Table 28 : AMERICAS CHF MARKET BY DRUG TYPE, THROUGH 2016Table 29 : AMERICAS CHF MARKET SHARES BY DRUG TYPE, 2011Figure 9 : AMERICAS CHF MARKET SHARES BY DRUG TYPE, 2011Table 30 : AMERICAS CHF MARKET SHARES BY DRUG TYPE, 2016Figure 10 : AMERICAS CHF MARKET SHARES BY DRUG TYPE, 2016Table 31 : U.S. CHF MARKET BY DRUG TYPE, THROUGH 2016Table 32 : CANADIAN CHF MARKET BY DRUG TYPE, THROUGH 2016Table 33 : LATIN AMERICAN/SOUTH AMERICAN CHF MARKET BY DRUG TYPE, THROUGH2016Chapter- 6: THE EUROPEAN MARKETREGIONAL MARKETSREGIONAL DEMOGRAPHICSEUROPEAN MARKET FORECASTTable 40 : EUROPEAN CHF PHARMACEUTICALS MARKET BY GEOGRAPHIC REGION,THROUGH 2016Figure 11 : EUROPEAN CHF PHARMACEUTICALS MARKET BY GEOGRAPHIC REGION, 2011Figure 12 : EUROPEAN CHF PHARMACEUTICALS MARKET BY GEOGRAPHIC REGION, 2016Table 41 : EUROPEAN CHF MARKET BY DRUG TYPE, THROUGH 2016Table 42 : EUROPEAN MARKET SHARES OF CHF PHARMACEUTICALS BY TYPE, 2011Figure 13 : EUROPEAN MARKET SHARES OF CHF PHARMACEUTICALS BY TYPE, 2011Table 43 : EUROPEAN MARKET SHARES OF CHF PHARMACEUTICALS BY TYPE, 2016Figure 14 : EUROPEAN MARKET SHARES OF CHF PHARMACEUTICALS BY TYPE, 2016Table 44 : CHF MARKET IN FRANCE BY DRUG TYPE, THROUGH 2016Table 45 : CHF MARKET IN GERMANY BY DRUG TYPE, THROUGH 2016Table 46 : CHF MARKET IN ITALY BY DRUG TYPE, THROUGH 2016Table 47 : CHF MARKET IN SPAIN BY DRUG TYPE, THROUGH 2016
  • Table 48 : U.K. CHF MARKET BY DRUG TYPE, THROUGH 2016Chapter- 7: THE ASIAN MARKETDEMOGRAPHICSREGIONAL MARKETSASIAN CHF MARKET FORECASTTable 52 : ASIAN CHF MARKET BY GEOGRAPHIC REGION, THROUGH 2016Figure 15 : ASIAN CHF MARKET BY GEOGRAPHIC REGION, 2011Figure 16 : ASIAN CHF MARKET BY GEOGRAPHIC REGION, 2016Table 53 : ASIAN CHF MARKET BY DRUG TYPE, THROUGH 2016Table 54 : ASIAN CHF MARKET SHARES BY DRUG TYPE, 2011Figure 17 : ASIAN CHF MARKET SHARES BY DRUG TYPE, 2011Table 55 : ASIAN CHF MARKET SHARES BY DRUG TYPE, 2016Figure 18 : ASIAN CHF MARKET SHARES BY DRUG TYPE, 2016Table 56 : JAPAN’S CHF MARKET BY DRUG TYPE, THROUGH 2016Table 57 : CHINA’S CHF MARKET BY DRUG TYPE, THROUGH 2016Chapter- 8: REST-OF-WORLD/EMERGING MARKETSREGIONAL DEMOGRAPHICSREGIONAL MARKETSROW MARKET FORECASTChapter- 9: COMPANY PROFILESABBOTT LABORATORIESARCA BIOPHARMAASTRAZENECAAUROBINDO PHARMABAYER AGBIOHEART, INC.BOEHRINGER INGELHEIM GMBHBRISTOL-MYERS SQUIBB CO.CARDIOKINE, INC.DR. REDDY’S LABORATORIES, LTD.FOREST LABORATORIES, INC.GLAXOSMITHKLINEMERCKMITSUBISHI TANABE PHARMA CORP.MYLAN, INC.NEUROCRINE BIOSCIENCESNOVARTISPFIZER, INC.SANOFI-AVENTIS, INC.SERVIERSHIONOGI & CO., LTD.TAKEDA PHARMACEUTICALS CO., LTD.TEVAChapter- 10: APPENDIX: DIRECTORY OF COMPANIESList of Tables
  • Summary Table : TOTAL GLOBAL MARKET SIZE AND FORECAST FOR CHFPHARMACEUTICALS, THROUGH 2016Table 1 : TOTAL GLOBAL POPULATION BY SELECTED GEOGRAPHIC REGION, 2000–2050Table 2 : SELECTED ACE INHIBITORS AVAILABLE FOR THE TREATMENT OF CHFTable 3 : SELECTED ANGIOTENSIN II RECEPTOR BLOCKERS AVAILABLE FOR THETREATMENT OF CHFTable 4 : SELECTED BETA-ADRENERGIC RECEPTOR BLOCKING AGENTS AVAILABLE FORTHE TREATMENT OF CHFTable 5 : SELECTED DIURETIC AGENTS AVAILABLE FOR TREATMENT OF CHFTable 6 : SELECTED POSITIVE INOTROPIC DRUGS AVAILABLE FOR THE TREATMENT OF CHFTable 7 : SELECTED VASODILATORS AVAILABLE FOR THE TREATMENT OF CHFTable 8 : PRODUCTS IN DEVELOPMENT TO TREAT CHFTable 9 : GLOBAL MARKET FORECAST FOR CHF PHARMACEUTICALS BY REGION, THROUGH2016Table 10 : GLOBAL MARKET SHARES OF CHF PHARMACEUTICAL REVENUES BY REGION,2011Table 11 : GLOBAL CHF MARKET BY DRUG TYPE, THROUGH 2016Table 12 : GLOBAL CHF MARKET SHARES BY DRUG TYPE, 2011Table 13 : GLOBAL CHF MARKET SHARES BY DRUG TYPE, 2016Table 14 : GLOBAL CHF PHARMACEUTICAL MARKET BY COMPANY, 2011Table 15 : GLOBAL CHF MANUFACTURER PRODUCT PARTICIPATION BY DRUG TYPETable 16 : CHF POPULATION IN THE AMERICAS BY COUNTRY, 2011Table 17 : U.S.’ OLDER POPULATION BY AGE GROUP & CENSUS YEAR, 2000–2050Table 18 : CANADA’S OLDER POPULATION BY AGE GROUP AND CENSUS YEAR, 2000–2050Table 19 : BRAZIL’S OLDER POPULATION BY AGE GROUP AND CENSUS YEAR, 2000–2050Table 20 : MEXICO’S OLDER POPULATION BY AGE GROUP AND CENSUS YEAR, 2000–2010Table 21 : VENEZUELA’S OLDER POPULATION BY AGE GROUP AND CENSUS YEAR, 2000–2050Table 22 : ARGENTINA’S OLDER POPULATION BY AGE GROUP AND CENSUS YEAR, 2000–2050Table 23 : PERU’S OLDER POPULATION BY AGE GROUP AND CENSUS YEAR, 2000–2050Table 24 : CHILE’S OLDER POPULATION BY AGE GROUP AND CENSUS YEAR, 2000–2050Table 25 : COLOMBIA’S OLDER POPULATION BY AGE GROUP AND CENSUS YEAR, 2000–2050Table 26 : CUBA’S OLDER POPULATION BY AGE GROUP AND CENSUS YEAR, 2000–2050Table 27 : AMERICAS CHF PHARMACEUTICAL MARKET BY GEOGRAPHIC REGION, THROUGH2016Table 28 : AMERICAS CHF MARKET BY DRUG TYPE, THROUGH 2016Table 29 : AMERICAS CHF MARKET SHARES BY DRUG TYPE, 2011Table 30 : AMERICAS CHF MARKET SHARES BY DRUG TYPE, 2016Table 31 : U.S. CHF MARKET BY DRUG TYPE, THROUGH 2016Table 32 : CANADIAN CHF MARKET BY DRUG TYPE, THROUGH 2016Table 33 : LATIN AMERICAN/SOUTH AMERICAN CHF MARKET BY DRUG TYPE, THROUGH2016Table 34 : EUROPEAN CHF POPULATION BY COUNTRY, 2011Table 35 : FRANCE’S OLDER POPULATION BY AGE AND YEAR, 2000–2050Table 36 : GERMANY’S OLDER POPULATION BY AGE GROUP AND CENSUS YEAR, 2000–2050Table 37 : ITALY’S OLDER POPULATION BY AGE GROUP AND CENSUS YEAR, 2000–2050Table 38 : SPAIN’S OLDER POPULATION BY AGE GROUP AND CENSUS YEAR, 2000–2050Table 39 : U.K.’S OLDER POPULATION BY AGE GROUP AND CENSUS YEAR, 2000–2050Table 40 : EUROPEAN CHF PHARMACEUTICALS MARKET BY GEOGRAPHIC REGION,
  • THROUGH 2016Table 41 : EUROPEAN CHF MARKET BY DRUG TYPE, THROUGH 2016Table 42 : EUROPEAN MARKET SHARES OF CHF PHARMACEUTICALS BY TYPE, 2011Table 43 : EUROPEAN MARKET SHARES OF CHF PHARMACEUTICALS BY TYPE, 2016Table 44 : CHF MARKET IN FRANCE BY DRUG TYPE, THROUGH 2016Table 45 : CHF MARKET IN GERMANY BY DRUG TYPE, THROUGH 2016Table 46 : CHF MARKET IN ITALY BY DRUG TYPE, THROUGH 2016Table 47 : CHF MARKET IN SPAIN BY DRUG TYPE, THROUGH 2016Table 48 : U.K. CHF MARKET BY DRUG TYPE, THROUGH 2016Table 49 : ASIAN CHF POPULATION BY COUNTRY, 2011Table 50 : JAPAN’S OLDER POPULATION BY AGE GROUP AND CENSUS YEAR, 2000–2050Table 51 : CHINA’S OLDER POPULATION BY AGE GROUP AND CENSUS YEAR, 2000–2050Table 52 : ASIAN CHF MARKET BY GEOGRAPHIC REGION, THROUGH 2016Table 53 : ASIAN CHF MARKET BY DRUG TYPE, THROUGH 2016Table 54 : ASIAN CHF MARKET SHARES BY DRUG TYPE, 2011Table 55 : ASIAN CHF MARKET SHARES BY DRUG TYPE, 2016Table 56 : JAPAN’S CHF MARKET BY DRUG TYPE, THROUGH 2016Table 57 : CHINA’S CHF MARKET BY DRUG TYPE, THROUGH 2016Table 58 : THE REST OF THE WORLD’S CHF POPULATION BY COUNTRY, 2011Table 59 : AUSTRALIA’S OLDER POPULATION BY AGE GROUP AND CENSUS YEAR, 2000–2050Table 60 : INDIA’S OLDER POPULATION BY AGE GROUP AND CENSUS YEAR, 2000–2050Table 61 : ISRAEL’S OLDER POPULATION BY AGE GROUP AND CENSUS YEAR, 2000–2050Table 62 : RUSSIA’S OLDER POPULATION BY AGE GROUP AND CENSUS YEAR, 2000–2050Table 63 : REST OF WORLD CHF PHARMACEUTICAL MARKET BY GEOGRAPHIC REGION,THROUGH 2016Table 64 : REST OF WORLD CHF MARKET BY DRUG TYPE, THROUGH 2016Table 65 : REST OF WORLD CHF MARKET SHARES BY DRUG TYPE, 2011Table 66 : REST OF WORLD CHF MARKET SHARES BY DRUG TYPE, 2016Table 67 : AUSTRALIAN CHF MARKET BY DRUG TYPE, THROUGH 2016Table 68 : INDIA’S CHF MARKET BY DRUG TYPE, THROUGH 2016Table 69 : ISRAEL/THE MIDDLE EAST’S CHF MARKET BY DRUG TYPE, THROUGH 2016Table 70 : RUSSIAN CHF MARKET BY DRUG TYPE, THROUGH 2016Table 71 : OTHER CHF MARKETS BY DRUG TYPE, THROUGH 2016List of FiguresSummary Figure : TOTAL GLOBAL MARKET SIZE AND FORECAST FOR CHFPHARMACEUTICALS, 2010–2016Figure 1 : TOTAL GLOBAL POPULATION BY SELECTED GEOGRAPHIC REGION, 2000–2050Figure 2 : GLOBAL MARKET FORECAST FOR CHF PHARMACEUTICALS BY REGION, 2010–2016Figure 3 : GLOBAL MARKET SHARES OF CHF PHARMACEUTICAL REVENUES BY REGION,2011Figure 4 : GLOBAL CHF MARKET BY DRUG TYPE, 2010-2016Figure 5 : GLOBAL CHF MARKET SHARES BY DRUG TYPE, 2011Figure 6 : GLOBAL CHF MARKET SHARES BY DRUG TYPE, 2016Figure 7 : GLOBAL CHF PHARMACEUTICAL MARKET SHARES BY COMPANY, 2011Figure 8 : AMERICAS CHF MARKET BY GEOGRAPHIC REGION, 2011Figure 9 : AMERICAS CHF MARKET SHARES BY DRUG TYPE, 2011Figure 10 : AMERICAS CHF MARKET SHARES BY DRUG TYPE, 2016
  • Figure 11 : EUROPEAN CHF PHARMACEUTICALS MARKET BY GEOGRAPHIC REGION, 2011Figure 12 : EUROPEAN CHF PHARMACEUTICALS MARKET BY GEOGRAPHIC REGION, 2016Figure 13 : EUROPEAN MARKET SHARES OF CHF PHARMACEUTICALS BY TYPE, 2011Figure 14 : EUROPEAN MARKET SHARES OF CHF PHARMACEUTICALS BY TYPE, 2016Figure 15 : ASIAN CHF MARKET BY GEOGRAPHIC REGION, 2011Figure 16 : ASIAN CHF MARKET BY GEOGRAPHIC REGION, 2016Figure 17 : ASIAN CHF MARKET SHARES BY DRUG TYPE, 2011Figure 18 : ASIAN CHF MARKET SHARES BY DRUG TYPE, 2016Figure 19 : REST OF WORLD CHF PHARMACEUTICAL MARKET BY GEOGRAPHIC REGION,2010-2016Figure 20 : REST OF WORLD CHF MARKET SHARES BY DRUG TYPE, 2011Figure 21 : REST OF WORLD CHF MARKET SHARES BY DRUG TYPE, 2016About Us:ReportsnReports is an online library of over 100,000+ market research reports and in-depthmarket research studies & analysis of over 5000 micro markets. We provide 24/7 online andoffline support to our customers. Get in touch with us for your needs of market researchreports.Follow us on Twitter: http://twitter.com/marketsreportsOur Facebook Page: http://www.facebook.com/pages/ReportsnReports/191441427571689Contact:Mr.Priyank7557 Rambler road,Suite727,Dallas,TX75231Tel: + 1 888 391 5441E-mail: sales@reportsandreports.comhttp://www.reportsnreports.comVisit our Market Research Blog